Search company, investor...

Ambrilia Biopharma

Stage

Other Investors | Alive

About Ambrilia Biopharma

Ambrilia Biopharma Inc. is a biotechnology company focused on the discovery and development of novel treatments for viral diseases and cancer. The Company's strategy aims to capitalize on its broad portfolio and original expertise in virology.Ambrilia's product portfolio is comprised of oncology and antiviral assets, including two new formulations of existing peptides for cancer treatment, a therapeutic peptide for prostate cancer, a targeted delivery technology for cancer, HIV protease, integrase and entry inhibitors, HCV entry and polymerase inhibitors and Anti-Influenza A compounds.

Headquarters Location

Canada

Missing: Ambrilia Biopharma's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: Ambrilia Biopharma's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Expert Collections containing Ambrilia Biopharma

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Ambrilia Biopharma is included in 1 Expert Collection, including Cancer.

C

Cancer

3,605 items

Companies researching, developing, or offering products & services that aid in the screening, prevention, diagnosis, management, and treatment of cancer.

Ambrilia Biopharma Patents

Ambrilia Biopharma has filed 1 patent.

patents chart

Application Date

Grant Date

Title

Related Topics

Status

1/11/2011

10/9/2012

HIV/AIDS, Hepatotoxins, Piperazines, Virology, Molecular biology

Grant

Application Date

1/11/2011

Grant Date

10/9/2012

Title

Related Topics

HIV/AIDS, Hepatotoxins, Piperazines, Virology, Molecular biology

Status

Grant

Latest Ambrilia Biopharma News

Bone Marrow Market Industry Perspective, Comprehensive Analysis, Trends and Forecast, 2028 AGendia, Agilent Technologies, Inc., Ambrilia Biopharma Inc., Astellas Pharma Inc

Jan 7, 2022

Search jobs 07-Jan-2022 Bone Marrow Market Industry Perspective, Comprehensive Analysis, Trends and Forecast, 2028 AGendia, Agilent Technologies, Inc., Ambrilia Biopharma Inc., Astellas Pharma Inc Bone Marrow Market analysis report gives a clear idea on various segments that are relied upon to observe the quickest business development amid the estimated forecast frame. This report indicates a professional and all-inclusive study of the market which concentrates on primary and secondary drivers, market share, competitor analysis, leading segments and geographical analysis. With the particular base year and the historic year, definite estimations and calculations are carried out in this business report. The global Bone Marrow Market report displays a comprehensive study on production capacity, consumption, import, and export for all the major regions across the globe. The report refers to standard research methodologies to offer entire and precise market analysis, statistical assessment and an upright industry projection. The Bone Marrow market report offers a profound study derived from various analytical tools that elaborate about forthcoming opportunities to facilitate strategic and tactical business decisions to improve profitability. The report provides such enlightenment of the Bone Marrow industry that helps to monitor the performance of the market is surrounded by the rapid evolvements and aggressive competitiveness. Get Latest Free Exclusive Sample (350 Pages PDF) Report: To Know the Impact of COVID-19 on Bone Marrow Market Report:  https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-bone-marrow-market The bone marrow market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses that the market is growing with the CAGR of 5.22% in the forecast period of 2021 to 2028 and is estimated to reach 13,899.60 USD Million by 2028. The growing amount of bone marrow diseases will help in escalating the growth of the bone marrow market. Later on, the report assesses gross sales (volume & value), market share, market size, market growth rate based variety of applications. The Bone Marrow report also focuses on regional and provincial markets to analyze manufacturers, niche market segments, industry environment, raw material resources, and rivalry of the specific marketplace. Key Players in Bone Marrow Market covers the complete in-depth information, which in brief covers there: Regional Market Analysis To Receive an Extensive List of Important Regions, Ask For TOC Here:  https://www.databridgemarketresearch.com/toc/?dbmr=global-bone-marrow-market While performing in a specific industry it is highly essential to determine forthcoming possibilities, therefore the Bone Marrow market report covers all-inclusive evaluation based on upcoming business and investment opportunities, market restraining factors, business threats, challenges, regulatory alliance as well as industry environment. With the help of the proposed valuable insight reader could achieve its predetermined business goals. Additionally, the report converse about lucrative business strategies implemented by key competitors, which might include recent acquisitions, partnerships, amalgamations, wind-ups, and product launches. It also offers a detailed explanation of the competitive landscape on a minute level that provides a wise acumen to a reader to be ahead of the curve. Prominent Key Players – Covered in the report:  AGendia, Agilent Technologies, Inc., Ambrilia Biopharma Inc., Astellas Pharma Inc., diaDexus, Illumina, Inc., QIAGEN, F Hoffmann-La Roche Ltd, Sanofi, Stryker Corporation, PromoCell GmbH, STEMCELL Technologies Inc., Lonza, ReachBio LLC, AllCells, ATCC, Lifeline Cell Technology., Conversant bio, HemaCare, Mesoblast Ltd., Merck KGaA, Discovery Life Sciences., ReeLabs Pvt. Ltd., Gamida Cell, (Customization Available) Why choose us: We share precise and exact information about the market forecast Our reports have been examined by professional experts of the industry, which makes them beneficial for the company to maximize their return on investment The analysis acknowledges that the sector players key drivers of both conflicts and Bone Marrow growth assess the impact of limitations as well as the opportunities on the sector Data regarding Bone Marrow industry share by every item fragment, alongside their reasonable worth, have been served in the report We provide statistical information, strategic and analysis tool results to provide a sophisticated landscape and target key market players. This will help the company to increase its efficiency Our report helps readers decipher the current and future constraints of the Bone Marrow market and optimal business strategies to enhance market development; Table of Content: Chapter 1: Bone Marrow Overview, Product Overview, Market Segmentation, Market Overview of Regions, Market Dynamics, Limitations, Opportunities and Industry News and Policies. Chapter 2: PEST (Political, Economic, Social and Technological) Analysis of Bone Marrow Market. Chapter 3: Value Analysis, Production, Growth Rate and Price Analysis by Type of Bone Marrow. Chapter 4: Downstream Characteristics, Consumption and Market Share by Application of Bone Marrow. Chapter 5: Production Volume, Price, Gross Margin, and Revenue ($) of Bone Marrow by Regions. Chapter 6: Bone Marrow Production, Consumption, Export, Market Trends and Competitive Landscape. Chapter 7: Bone Marrow Market Status and SWOT Analysis by Regions. Chapter 8: Competitive Landscape, Product Introduction, Company Profiles, Market Distribution Status by Players of Bone Marrow. Chapter 9: Bone Marrow Market Analysis and Forecast by Type and Application. Chapter 10: Market Analysis and Forecast by Regions. Chapter 11: Industry Characteristics, Key Factors, New Entrants SWOT Analysis, Investment Feasibility Analysis. Chapter 12: Market Conclusion. Chapter 13: Appendix Such as Methodology and Data Resources of This Research. “If you have any customized requirements that need to be added, we will be happy to include them to enrich the final research study.” For Any Query or Customization need to add in “Bone Marrow Market Report” Kindly Follow this URL:  https://www.databridgemarketresearch.com/inquire-before-buying/?dbmr=global-bone-marrow-market

Ambrilia Biopharma Frequently Asked Questions (FAQ)

  • What is Ambrilia Biopharma's latest funding round?

    Ambrilia Biopharma's latest funding round is Other Investors.

  • Who are the investors of Ambrilia Biopharma?

    Investors of Ambrilia Biopharma include BDC Venture Capital.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.